Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial

JAMA Intern Med. 2021 Sep 1;181(9):1237-1239. doi: 10.1001/jamainternmed.2021.1184.

Peter J Gallacher¹, Eve Miller-Hodges^{1

2}, Anoop S V Shah^{1

3}, Atul Anand¹, Neeraj Dhaun^{1

2}, Nicholas L Mills^{1

4}; High-STEACS Investigators

High-STEACS Investigators:
Nicholas L Mills, Fiona E Strachan, Christopher Tuck, Anoop Sv Shah, Atul Anand, Tariq Farrar, Nynke Halbesma, James Blackmur, Andrew R Chapman, Amy V Ferry, Kuan Ken Lee, Dennis Sandeman, Philip D Adamson, Catherine L Stables, Catalina A Vallejos, Athanasios Tsanas, Lucy Marshall, Stacey D Stewart, Takeshi Fujisawa, Mischa Hautvast, Jean McPherson, Lynn McKinlay, David E Newby, Keith Aa Fox, Colin Berry, Simon Walker, Christopher J Weir, Alasdair Gray, Paul O Collinson, Fred S Apple, Alan Reid, Anne Cruikshank, Iain Findlay, David A McAllister, Donogh Maguire, Jack Pm Andrews, Alastair Moss, Mohamed S Anwar, John Hung, Jonathan Malo, Colin Fischbacher, Bernard L Croal, Stephen J Leslie, Catriona Keerie, Richard A Parker, Allan Walker, Ronnie Harkess, Tony Wackett, Roma Armstrong, Laura Stirling, Claire MacDonald, Imran Sadat, Frank Finlay, Heather Charles, Pamela Linksted, Stephen Young, Bill Alexander, Chris Duncan

¹ BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland.
² Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, Scotland.
³ London School of Hygiene and Tropical Medicine, London, England.
⁴ Usher Institute, University of Edinburgh, Edinburgh, Scotland.

Abstract

This randomized clinical trial examines the use of high-sensitivity cardiac troponin testing for patients with kidney impairment.